About John Tomes
John Tomes is director of finance at Mercury Bio, which develops medicines for Parkinson’s and Alzheimer’s disease.
Before Mercury Bio, Tomes was a senior partner at Hawthorn Equity Partners and a managing director at GE Capital. He has more than 25 years of private equity and early-stage investing experience across four funds managing over $450 million. At GE Capital, he sourced and managed more than 70 lending and equity investments totaling $5.5 billion. He also managed four U.S. offices. His transaction work includes company sales and mergers, public offerings, and restructurings. He has served on more than 15 boards, including Hydrofarm. He earned a biology degree from Kenyon College and an MBA from the University of Chicago.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name John Tomes in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Tomes works with at each company, as listed on that company's latest Form D.
